The U.S. Healthcare COVID-19 Portal is designed to streamline the process by which health care facilities across the nation report their COVID-19-related data (e.g. total COVID-19 confirmed patients, N95 inventory, etc.). Now, instead of submitting data through multiple outlets, health care facilities can rely on the portal as a single platform through which to submit data to the U.S. Department of Health and Human Services (HHS).

Monoclonal Antibody Therapeutics Reporting

Weekly reporting on use of federally purchased COVID-19 therapeutics is required every Wednesday. Sites that use these therapies are required to report through HHS Protect, TeleTracking, or CDC’s National Healthcare Safety Network (NHSN) depending on facility type.

To receive an invitation, please send an email to with the subject “New Therapeutic Facility Request” with this template filled out as completely as possible, with Name, Address, and at least one of NPI, CCN, Tax ID, DEA ID, AHA ID, HHS ID, or NHSN ID being mandatory.

The silent video below demonstrates the steps for entering new data that are explained here.

To begin entering data for your facility, complete the following tasks (Google Chrome is the recommended browser):

  1. Create a portal account.
  2. Review the descriptions for each of the data points to be entered into the portal.
  3. Enter data for your facility.

Once you've submitted your first data entry, you'll also have the ability to view previous entries and update data.

Keep in mind that you cannot edit a previous entry, but you can still update your hospital's numbers by submitting a new one. The HHS will receive data based on the latest entry, which will be collected routinely by the server.

You can also add other members of your facility as users to help report data.

See our Release Notes for the latest information on new features and user interface updates.

Technical Support

To contact technical support for the U.S. Healthcare COVID-19 Portal at:


Press 7 to get direct access to support specifically for the COVID-19 Portal.

You can also email questions to